Add BrightSurf on Google Email

Mechanism of action of the hepatitis B and D virus cell entry inhibitor bulevirtide deciphered

Researchers deciphered the molecular structure of bulevirtide in complex with HBV/HDV receptor NTCP, revealing a unique 'plug' that inhibits virus entry. The study also sheds light on evolutionary adaptation of HBVs to host species and provides insights for developing smaller, more effective active agents.

SourceGerman Center for Infection Research·JournalNature Communications·TypeExperimental study·DateApr 10, 2024

Chinese Medical Journal Review highlights novel pathogenic mechanisms and therapeutic potentials in cancer treatment targeting internal N6-methyladenosine and N7-methylguanine

Researchers highlight the role of post-transcriptional RNA modifications in AML pathogenesis, identifying m6A and m7G regulators as potential therapeutic targets. Targeted therapies, including selective inhibitors and Traditional Chinese Medicine compounds, show promise in promoting cell differentiation and reversing AML phenotypes.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateApr 10, 2024

Unnecessary use of beta-blockers after a heart attack

A new study published in the New England Journal of Medicine found that half of patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. The study shows that these patients have suffered a small heart attack and have retained heart function afterwards.

SourceKarolinska Institutet·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 8, 2024

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: a leap toward personalized medicine

A retrospective cohort study found that PERT significantly reduced the incidence of acute pancreatitis episodes among children with recurrent or chronic pancreatitis. The study also identified genetic markers, such as SPINK1 mutation, that influence treatment outcomes and suggest a tailored approach to patient care.

SourceOchsner Health System·JournalThe American Journal of Gastroenterology·DateMar 27, 2024

Using machine learning to save lives in the ER

A study published in Critical Care identified eight different trauma phenotypes associated with lower in-hospital mortality when treated with tranexamic acid. The researchers used a machine learning model to analyze data from over 50,000 patients and found subgroups of patients who received no benefit from treatment.

SourceOsaka University·JournalCritical Care·TypeObservational study·DateMar 26, 2024

New evidence-based guideline for the management of osteoporosis in men

The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis have issued new guidelines for managing osteoporosis in men. These recommendations cover disease burden, fracture risk assessment, treatment thresholds, and interventions to reduce the substantial morbidity and mortality ass...

SourceInternational Osteoporosis Foundation·JournalNature Reviews Rheumatology·TypeLiterature review·DateMar 25, 2024

Fast folding for synthetic peptides and microproteins

Researchers at Xi'an Jiaotong-Liverpool University developed a new method that enables the efficient production of cysteine-rich peptides and microproteins in their naturally folded 3D structure. The approach uses organic solvents to mimic nature's oxidative folding process, resulting in speeds of over 100,000 times faster than aqueous...

SourceXi'an Jiaotong-Liverpool University·JournalAngewandte Chemie·TypeExperimental study·DateMar 21, 2024

Digital twin allows for tailored medication

A study published in Genome Medicine uses digital twins to computationally treat thousands of medications in individual patients with autoimmune diseases, finding promising results in mice and human tissue samples. The technology has the potential to revolutionize precision medicine by providing tailored medication for each patient.

SourceKarolinska Institutet·JournalGenome Medicine·DateMar 20, 2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

A new genetic test has identified patients with triple negative early-stage breast cancer who are unlikely to respond to immunotherapy drugs. The test, called ImPrintTN, can predict a patient's likelihood of responding to these treatments and help avoid severe side effects.

SourceEuropean Organisation for Research and Treatment of Cancer·TypeRandomized controlled/clinical trial·DateMar 19, 2024

Addressing both flu and COVID-19 through a single, multitasking injection

A new multitasking substance has been identified to prevent and treat both flu and COVID-19 infections concurrently. The long-acting recombinant cytokine protein rhIL-7-hyFc demonstrated therapeutic and preventive effects against various respiratory diseases, including COVID-19, influenza virus, and respiratory syncytial virus.

SourcePohang University of Science & Technology (POSTECH)·JournalCell Reports Medicine·DateMar 18, 2024

Therapy using intense light and chronological time can benefit heart

A new study from the University of Colorado Anschutz Medical Campus suggests that managing circadian rhythms through intense light and chronologically timed therapy can help prevent or treat various circulatory system conditions, including heart disease. The research found that intense light stabilizes the PER2 gene and increases level...

SourceUniversity of Colorado Anschutz Medical Campus·JournalCirculation Research·TypeObservational study·DateMar 14, 2024

UChicago Medicine helps bring first-of-its-kind drug for metabolic liver disease to the clinic

Resmetirom, a new medication, has been approved to treat metabolic dysfunction-associated steatohepatitis (MASH), a more advanced stage of MASLD characterized by liver inflammation and scarring. The drug was shown to improve fibrosis and reduce disease progression in patients with MASLD.

SourceUniversity of Chicago Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 14, 2024

Exploring the therapeutic potential of natural mushroom compounds to address psychiatric disorders

A new study suggests that mushroom extract containing psilocybin demonstrates superior efficacy in stimulating neuroplasticity and promoting new connections between nerve cells. The research found that the extract had a more potent and prolonged impact on synaptic plasticity compared to chemically synthesized psilocybin.

SourceThe Hebrew University of Jerusalem·JournalMolecular Psychiatry·TypeExperimental study·DateMar 11, 2024

Researchers develop artificial building blocks of life

Scientists from the University of Cologne developed threofuranosyl nucleic acid (TNA) with a new base pair, offering improved stability and function compared to natural DNA and RNA. This breakthrough could enable targeted drug delivery, diagnostics, and recognition of viral proteins or biomarkers.

SourceUniversity of Cologne·JournalJournal of the American Chemical Society·TypeExperimental study·DateMar 8, 2024

New study finds high-dose inhaled nitric oxide decreases the risk of death among critically ill Black patients with COVID-19

A new study found that high-dose inhaled nitric oxide improves oxygenation and reduces mortality risk among critically ill Black patients with COVID-19. The treatment was more effective for Black patients, who have a suppressed nitric oxide system at baseline.

SourceUniversity of Alabama at Birmingham·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeData/statistical analysis·DateFeb 28, 2024

AGA announces 12-point plan to improve the care of all patients with inflammatory bowel disease (IBD)

The American Gastroenterological Association has proposed a 12-point plan to enhance IBD care in the US, focusing on insurer-mandated barriers such as prior authorization and step therapy. The plan aims to improve treatment access and quality for over three million Americans living with IBD.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateFeb 28, 2024

Journal of Pharmaceutical Analysis articles provide novel insights into previously unknown disease mechanisms

Researchers decode underlying mechanisms of DCM, hippocampal neurotoxicity, and dysbiosis mediated AD progression using mass spectrometry imaging. The studies found metabolic changes in DCM rat hearts and regulation of CYPs in the hippocampus, providing new perspectives on treatment strategies.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 26, 2024

μkiss-and-tell: A new method for precision delivery of nanoparticles and small molecules to individual cells

Scientists create 'μkiss' technique for precise delivery of materials to individual cells, offering new possibilities in single-cell science and next-generation therapeutic applications. The method provides full control over location, time, and scale of material application, enabling detailed studies of cellular processes.

SourceMax Planck Institute for the Science of Light·JournalNature Methods·TypeExperimental study·DateFeb 21, 2024

With regular exercise, medical weight loss treatment does not have to be permanent

A new study published in LANCET eClinicalMedicine found that regular exercise can help individuals maintain weight loss after completing medical weight loss treatment. The study showed that exercising just two hours a week can lead to better quality of life, improved mental health, and reduced fatigue.